个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Liang, W.[1] ; Jiang, S.[1] ; Chai, Y.[2] ; Liu, W.[3] ; Liu, L.[4] ; Song, P.[5] ; Wang, Z.[6] ; Zhang, S.[7] ; Xin, H.[8] ; Liu, X.[9] ; Xu, S.[10] ; Zhang, H.[11] ; Han, Y.[12] ; Shen, W.[13] ; Peng, Z.[14] ; Geng, M.[15] ; Yu, G.[16] ; Zhang, X.[17] ; He, J.[18] ;
机构： [1]Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou, Peoples R China [2]Zhejiang Univ, Affiliated Hosp 2, Dept Thorac Surg, Sch Med, East Gate 1, Hangzhou, Peoples R China [3]First Hosp Jilin Univ, Dept Thorac Surg, Changchun, Peoples R China [4]SCU Sichuan Univ, Thorac Surg, Huaxi Campus, Chengdu, Peoples R China [5]Shandong Univ, Shandong Canc Hosp, Dept Thorac Surg, Jinan, Peoples R China [6]Beijing TB & Thorac Tumor Res Inst, Dept Thorac Surg, Beijing, Peoples R China [7]China Med Univ, Shengjing Hosp, Thorac Surg Dept, Nanhu Campus, Shenyang, Peoples R China [8]Jilin Univ, Jilin Univ Third Hosp, China Japan Union Hosp, Thorac Surg Dept, Changchun, Peoples R China [9]Suzhou Municipal Hosp, Thorac Surg Dept, Suzhou, Peoples R China [10]Fudan Univ, Zhongshan Hosp, General Thorac Surg, Shanghai, Peoples R China [11]Shanxi Prov Canc Hosp, Thorac Surg, Taiyuan, Peoples R China [12]UESTC, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp Sch, Thorac Surg, Chengdu, Peoples R China [13]Lihuili Hosp Ningbo Med Treatment Ctr, Thorac Surg Dept, Ningbo, Peoples R China [14]Shandong Prov Hosp, Thorac Surg Dept, Jinan, Peoples R China [15]Anyang Tumor Hosp, Thorac Surg Dept, Anyang, Peoples R China [16]Shaoxing Peoples Hosp, Thorac Surg, Shaoxing, Peoples R China [17]Tianjin Chest Hosp, Thorac Surg Dept, Tianjin, Peoples R China [18]Guangzhou Med Univ, Affiliated Hosp 1, Thorac Surg Dept, Guangzhou, Guangdong, Peoples R China
出处：
ISSN：
基金：
AstraZeneca China
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2022]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714)：
Liang W.,Jiang S.,Chai Y.,et al.Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study[J].ANNALS OF ONCOLOGY.2022,33(7):S1062-S1063.
APA：
Liang, W.,Jiang, S.,Chai, Y.,Liu, W.,Liu, L....&He, J..(2022).Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study.ANNALS OF ONCOLOGY,33,(7)
MLA：
Liang, W.,et al."Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study".ANNALS OF ONCOLOGY 33..7(2022):S1062-S1063

资源点击量：43389 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号